BioSkryb Genomics is developing genomic amplification technologies to enhance single cell research. Much can be learned about disease from cellular heterogeneity within a sample by sequencing the DNA and RNA composition of single cells. However, datasets from single cells are incomplete. By using their patented Primary Template-directed Amplification and BaseJumper bioinformatics platform, BioSkryb can reveal multiple tiers of molecular information from a single cell. This can be seen in their recent product, ResolveOME, which offers a comprehensive, near-complete coverage of the genome and mRNA transcriptome from single cells. With higher quality data from single cells that can uncover the relationship between genes and disease, more precise and effective treatments can be developed.

<p>BioSkryb Genomics is developing genomic amplification technologies to enhance single cell research. Much can be learned about disease from cellular heterogeneity within a sample by sequencing the DNA and RNA composition of single cells. However, datasets from single cells are incomplete. By using their patented Primary Template-directed Amplification and BaseJumper bioinformatics platform, BioSkryb can reveal multiple tiers of molecular information from a single cell. This can be seen in their recent product, ResolveOME, which offers a comprehensive, near-complete coverage of the genome and mRNA transcriptome from single cells. With higher quality data from single cells that can uncover the relationship between genes and disease, more precise and effective treatments can be developed.</p>


BioSkyrb Genomics

Founded: 2018
Location: Durham, NC
Employee range: 1 - 10
Funding: $11.5M Seed Jan 2020

About:

Jobs: